INmune Bio Inc. INMB

Set alert

Price alert · INMB

All alert types
1.39 USD +0.01 +0.72%

As of Nov 3, 12:29 PM ET

Bid
1.38 × 2
Ask
1.39 × 1
1.37 Day range 1.42
1.09 52-week range 2.60
YTD
-10.90%
1 year
-22.78%
Open
1.40
Prev close
1.38
Mkt cap
43.03M
Vol
101.55K
Avg vol
330.47K
EPS
-0.67
P/E
0.00
Div yield
0.00%
More statistics
Low
1.37
High
1.42
Forward P/E
-2.23
Beta
1.85
Short ratio
18.08
Inst. own
24.32%
Dividend
0.00
Ex-div date
Earnings
Aug 1, 2024
50-d avg
5.27
200-d avg
7.78
1y target
19.83

MAX chart

Chart tools
Interval

Events in this range
  • Nov 9, 2020Rating: HC Wainwright & Co. · — → Buy
  • Apr 21, 2021Rating: B. Riley Securities · — → Buy
  • Jan 24, 2022Rating: B. Riley Securities · — → Buy
  • May 24, 2022Downgrade: B. Riley Securities · Buy → Neutral
  • May 24, 2022Rating: BTIG · — → Buy
  • Jun 1, 2023Rating: Baird · — → Outperform
  • Mar 28, 2024Earnings: -0.47; estimate 0; surprise —%
  • May 9, 2024Earnings: —; estimate 0; surprise —%
  • May 9, 2024Earnings: -0.61; estimate 0; surprise —%
  • Aug 1, 2024Earnings: -0.5; estimate 0; surprise —%
  • Aug 1, 2024Earnings: —; estimate 0; surprise —%
  • Oct 31, 2024Earnings: -0.6; estimate -0.49; surprise -22.45%
Signals (138)
NameDateAgo
SMA: BearishOct 12, 20263 weeks ago
MACD: Sell SignalOct 12, 20263 weeks ago
SMA: BearishSep 21, 20261 month ago
SMA: BullishJun 29, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BearishMay 18, 20265 months ago
SMA: BullishMay 11, 20265 months ago
SMA: BullishApr 13, 20266 months ago
RSI: OversoldMar 16, 20267 months ago
SMA: BearishJan 19, 20269 months ago
SMA: BullishJan 12, 20269 months ago
SMA: BearishDec 22, 202510 months ago
SMA: BullishDec 1, 202511 months ago
MACD: Buy SignalOct 13, 20251 year ago
RSI: OversoldJun 30, 20251 year ago
SMA: BearishJun 16, 20251 year ago
SMA: BearishJun 16, 20251 year ago
SMA: BullishJun 2, 20251 year ago
SMA: BearishMay 19, 20251 year ago

Newest 20 of 138.

Analyst view

Price target (mean) 19.83 +1326.9% upside
Target (low)
16.00
Target (mean)
19.83
Target (high)
22.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

INMB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.556-0.66 – -0.45-0.47-18.3%0-100.0%5
Next quarter-0.47-0.47 – -0.47-0.61+23.0%0-100.0%2
Current year-2.30-2.53 – -2.15-1.67-37.5%9.33K-94.0%5
Next year-2.04-2.39 – -1.54-2.30+11.0%0-100.0%5

Upgrades and downgrades

The latest rating changes

INMB analyst upgrades and downgrades
DateFirmActionFromTo
Jun 1, 2023BairdInitiated—Outperform
May 24, 2022BTIGMaintained—Buy
May 24, 2022B. Riley SecuritiesDowngradeBuyNeutral
Jan 24, 2022B. Riley SecuritiesMaintained—Buy
Apr 21, 2021B. Riley SecuritiesInitiated—Buy
Nov 9, 2020HC Wainwright & Co.Maintained—Buy
Sep 1, 2020BTIGInitiated—Buy
Jul 15, 2020HC Wainwright & Co.Maintained—Buy
May 15, 2020HC Wainwright & Co.Reiterated—Buy
Mar 12, 2020HC Wainwright & Co.Maintained—Buy
Dec 19, 2019Roth CapitalInitiated—Buy
Aug 21, 2019HC Wainwright & Co.Initiated—Buy
Mar 19, 2019Maxim GroupInitiated—Buy